FDA finalizes decision to end Lilly's GLP-1 shortage, analysts …
4 days ago · The FDA decided the shortage for Eli Lilly's GLP-1 tirzepatide has finally come to an end. ... The company's stock slid more than 13% on the news, trading at less than $0.30 per share. ...
This Is Huge News for Eli Lilly Investors | The Motley Fool
5 days ago · While Danish-based pharmaceutical company Novo Nordisk (NVO-17.83%) leads the GLP-1 market (thanks in large part to enthusiasm for its pioneering Ozempic drug), its chief rival Eli Lilly (LLY 1.35 ...
Lilly.com | Eli Lilly and Company
INDIANAPOLIS , Dec. 9, 2024 /PRNewswire/ -- Today, the board of directors of Eli Lilly and Company (NYSE: LLY) approved a new $15 billion share repurchase program. The company's prior $5 billion share repurchase program was completed in the fourth quarter of 2024.
Lilly announces $3 billion expansion of its recently acquired ...
INDIANAPOLIS, Dec. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a $3 billion expansion of the Kenosha County, Wisconsin, manufacturing facility that the company acquired earlier this year. This investment will extend the company's global parenteral (injectable) product manufacturing network, helping to meet the ...
All News | Eli Lilly and Company
Dec 9, 2024 · Lilly's latest press releases, stories, news resources and more.
Lilly announces new $4.5 billion site - the Lilly Medicine Foundry
INDIANAPOLIS, Oct. 2, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. This unique facility will give Lilly the ability to research new ways of producing medicines, while also scaling up ...
Lilly.com | Eli Lilly and Company
Nov 14, 2024 · INDIANAPOLIS , Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and member of the company's Executive Committee, effective immediately.
News Release - Eli Lilly and Company
INDIANAPOLIS, May 24, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion.
Lilly hits record high after Mounjaro fuels forecast raise, rival data
Aug 8, 2023 · Eli Lilly on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment, with shares soaring 18% to a record...
Eli Lilly looks to extend winning streak over broad market to 6 years
1 day ago · The drugmaker's ability to further expand available supply of its obesity and weight loss drugs is crucial.